State Street’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-974,643
| Closed | -$308M | – | 4430 |
|
2023
Q4 | $308M | Buy |
974,643
+45,673
| +5% | +$14.5M | 0.02% | 634 |
|
2023
Q3 | $157M | Buy |
928,970
+113,684
| +14% | +$19.2M | 0.01% | 897 |
|
2023
Q2 | $177M | Sell |
815,286
-181,249
| -18% | -$39.3M | 0.01% | 863 |
|
2023
Q1 | $181M | Buy |
996,535
+20,858
| +2% | +$3.79M | 0.01% | 820 |
|
2022
Q4 | $192M | Buy |
975,677
+98,832
| +11% | +$19.4M | 0.01% | 778 |
|
2022
Q3 | $197M | Sell |
876,845
-311,592
| -26% | -$70.1M | 0.01% | 739 |
|
2022
Q2 | $150M | Buy |
1,188,437
+161,930
| +16% | +$20.5M | 0.01% | 898 |
|
2022
Q1 | $130M | Buy |
1,026,507
+187,142
| +22% | +$23.7M | 0.01% | 1108 |
|
2021
Q4 | $110M | Sell |
839,365
-23,024
| -3% | -$3.02M | 0.01% | 1235 |
|
2021
Q3 | $105M | Buy |
862,389
+136,202
| +19% | +$16.7M | 0.01% | 1217 |
|
2021
Q2 | $82.8M | Buy |
726,187
+19,135
| +3% | +$2.18M | ﹤0.01% | 1449 |
|
2021
Q1 | $85M | Sell |
707,052
-67,527
| -9% | -$8.12M | ﹤0.01% | 1359 |
|
2020
Q4 | $78.7M | Sell |
774,579
-25,057
| -3% | -$2.55M | ﹤0.01% | 1335 |
|
2020
Q3 | $61.8M | Buy |
799,636
+38,290
| +5% | +$2.96M | ﹤0.01% | 1310 |
|
2020
Q2 | $84.9M | Buy |
761,346
+533,111
| +234% | +$59.4M | 0.01% | 1088 |
|
2020
Q1 | $16.4M | Buy |
228,235
+107,968
| +90% | +$7.77M | ﹤0.01% | 1966 |
|
2019
Q4 | $9.06M | Buy |
120,267
+59,937
| +99% | +$4.52M | ﹤0.01% | 2576 |
|
2019
Q3 | $985K | Buy |
+60,330
| New | +$985K | ﹤0.01% | 3400 |
|